Russia's RDIF: Sputnik V vaccine to be approved by 25 countries within weeks

FILE PHOTO: An empty vial of the second dose of the Sputnik V (Gam-COVID-Vac) vaccine is pictured at the San Martin hospital, in La Plata, on the outskirts of Buenos Aires, Argentina January 21, 2021. REUTERS/Agustin Marcarian

MOSCOW (Reuters) - The head of Russia’s RDIF sovereign wealth fund, Kirill Dmitriev, said on Tuesday the Sputnik V coronavirus vaccine would be approved for domestic use by 25 countries within the next few weeks.

“Our Sputnik V vaccine is now registered in 14 countries. We’ll have more than 25 registrations within the next couple of weeks,” Dmitriev told a virtual meeting of the World Economic Forum.

Reporting by Polina Ivanova; Writing by Maria Kiselyova; Editing by Andrew Heavens